title: Introduction to the HESI DART Drugs in Semen Consortium.
authors.affiliation: ILSI - Health and Environmental Sciences Institute, Washington, DC, United States. Electronic address: cchen@hesiglobal.org.
authors.forename: Connie L
authors.initials: CL
authors.lastname: Chen
authors.affiliation: Sanofi U.S., Inc., Bridgewater, NJ, United States.
authors.forename: Bruce K
authors.initials: BK
authors.lastname: Beyer
authors.affiliation: Lilly Research Laboratories, Indianapolis, IN, United States.
authors.forename: William J
authors.initials: WJ
authors.lastname: Breslin
authors.affiliation: Novartis Pharmaceutical Corporation, East Hanover, NJ, United States.
authors.forename: Anthony M
authors.initials: AM
authors.lastname: DeLise
authors.affiliation: Celgene Corporation, Summit, NJ, United States.
authors.forename: Julia Y
authors.initials: JY
authors.lastname: Hui
authors.affiliation: Amgen, Inc., Seattle, WA, United States.
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Moffat
authors.affiliation: Bristol-Myers Squibb, New Brunswick, NJ, United States.
authors.forename: Kary E
authors.initials: KE
authors.lastname: Thompson
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D018811:Maternal Exposure; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011247:Pregnancy; D012661:Semen / Q000378:metabolism*; D018675:Toxicity Tests / Q000379:methods
chemical_list: D004364:Pharmaceutical Preparations